Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carles Pericay

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Oncology Reports|May 16, 2013
microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkersAnna Brunet Vega, Carles Pericay, Irene Moya, et al.
The Oncologist|April 7, 2011
Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS studyMiguel Nogué, Antonieta Salud, Pilar Vicente, et al.
British Journal of Cancer|September 11, 2015
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line settingDiether Lambrechts, Bernard Thienpont, Vincent Thuillier, et al.
Journal of Proteome Research|July 8, 2016
Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass SpectrometryJulia Kuligowski, Daniel Sanjuan-Herráez, María A Vázquez-Sánchez, et al.
United European Gastroenterology Journal|August 8, 2018
Expression profile of circulating microRNAs in the Correa pathway of progression to gastric cancerSergio Lario, Anna Brunet-Vega, María E Quílez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2024
How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish studyMarilina Santero, Carolina Requeijo, Maria Jesus Quintana, et al.
BMC Palliative Care|July 12, 2020
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practiceBerta Laquente, Teresa Macarulla, Cristina Bugés, et al.
Cirugia Espanola|February 24, 2009
[Site of local surgery in adenocarcinoma of the rectum T2N0M0]Xavier Serra Aracil, Jordi Bombardó Juncá, Laura Mora López, et al.
The Oncologist|May 4, 2023
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal CancerAna Fernández Montes, Vicente Alonso Orduña, Elena Asensio Martínez, et al.
Cancers|September 28, 2023
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS StudyCarles Pericay, Ana Fernández Montes, Vicente Alonso Orduña, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Oncology Reports|May 16, 2013
microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkersAnna Brunet Vega, Carles Pericay, Irene Moya, et al.
The Oncologist|April 7, 2011
Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS studyMiguel Nogué, Antonieta Salud, Pilar Vicente, et al.
British Journal of Cancer|September 11, 2015
Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line settingDiether Lambrechts, Bernard Thienpont, Vincent Thuillier, et al.
Journal of Proteome Research|July 8, 2016
Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass SpectrometryJulia Kuligowski, Daniel Sanjuan-Herráez, María A Vázquez-Sánchez, et al.
United European Gastroenterology Journal|August 8, 2018
Expression profile of circulating microRNAs in the Correa pathway of progression to gastric cancerSergio Lario, Anna Brunet-Vega, María E Quílez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2024
How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish studyMarilina Santero, Carolina Requeijo, Maria Jesus Quintana, et al.
BMC Palliative Care|July 12, 2020
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practiceBerta Laquente, Teresa Macarulla, Cristina Bugés, et al.
Cirugia Espanola|February 24, 2009
[Site of local surgery in adenocarcinoma of the rectum T2N0M0]Xavier Serra Aracil, Jordi Bombardó Juncá, Laura Mora López, et al.
The Oncologist|May 4, 2023
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal CancerAna Fernández Montes, Vicente Alonso Orduña, Elena Asensio Martínez, et al.
Cancers|September 28, 2023
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS StudyCarles Pericay, Ana Fernández Montes, Vicente Alonso Orduña, et al.
Pageof 7